Using the SHEP Tet21N MYCN-regulatable system, Gamble et al. reported that MNA-NB cells were more sensitive to apoptosis induced by the MDM2-p53 antagonists Nutlin-3 and MI-63 than those without high MYCN expression. The gene discussed is TP53; the disease is neuroblastoma.